Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia.

Annie Andrieux1, Paul Salin, Annie Schweitzer

  • 1Laboratoire du Cytosquelette, INSERM U366 CEA, Département Réponse et Dynamique Cellulaire, Grenoble, France. annie.andrieux@cea.fr

Biological Psychiatry
|June 30, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ARMC2 loss impairs cilia structure and leads to primary ciliary dyskinesia symptoms in mouse organs.

Frontiers in cell and developmental biology·2026
Same author

Proper localization of the SCA13-linked K<sup>+</sup> channel in Purkinje neurons requires a microtubule-stabilizing protein.

Neurobiology of disease·2026
Same author

Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2-developmental and epileptic encephalopathy.

Epilepsia·2026
Same author

Experimental and computational analysis of REM sleep distributed cortical activity in mice.

Journal of neurophysiology·2025
Same author

The Mn-motif protein MAP6d1 assembles ciliary doublet microtubules.

Nature communications·2025
Same author

A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growth.

PLoS biology·2025

Microtubule stabilizers like epothilone D show promise for schizophrenia treatment. This study found epothilone D improved synaptic function and behavior in a mouse model of schizophrenia.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Cytoskeletal defects are implicated in schizophrenia.
  • STOP-null mice, lacking a microtubule-associated protein, model schizophrenia with synaptic and behavioral deficits.
  • These deficits are partially reversed by neuroleptic treatment.

Purpose of the Study:

  • To investigate the therapeutic potential of epothilone D, a microtubule stabilizer, in a mouse model of schizophrenia.
  • To assess epothilone D's effects on synaptic function and behavior in STOP-null mice.

Main Methods:

  • Mice were treated with epothilone D or vehicle.
  • Synaptic function was evaluated using electron microscopy and hippocampal electrophysiology.
  • Dopamine transmission was assessed electrochemically.

Related Experiment Videos

  • Behavioral changes were measured using maternal skills tests.

    • Main Results:

    • Epothilone D treatment increased synaptic vesicle pools in STOP-null mice.
    • The stabilizer ameliorated short- and long-term synaptic plasticity in glutamatergic neurons.
    • Significant behavioral improvements were observed in treated STOP-null mice.

    Conclusions:

    • Microtubule stabilization represents a potential therapeutic strategy for schizophrenia.
    • Epothilone D demonstrates beneficial effects on synaptic function and behavior, offering a novel treatment avenue.